Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients? 1999

J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
Department of Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
March 2010, Archives of Iranian medicine,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
January 2006, Drugs,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
April 1995, Lancet (London, England),
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
May 2007, Pediatric transplantation,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
January 2001, Transplantation proceedings,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
July 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
January 2007, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
April 2012, Chinese medical journal,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
February 1999, Therapeutic drug monitoring,
J S Scott, and G J Boyle, and P E Daubeney, and S A Miller, and Y Law, and F Pigula, and B P Griffith, and S A Webber
January 2021, American journal of medical genetics. Part A,
Copied contents to your clipboard!